over night Transgene is up slightly but has been hovering in the high 12 euros for the last 3 days.
Novartis is up overnight as a result (im assuming) of an announcement that it is expanding its focus on cancer immunotherapy research and has purchased Costim Pharmaceuticals to assist in its development of cancer immunotherapeutic drugs.
It will be interesting to see whether Transgenes (VHLs) patents fit within this developments as a component or to stave off competition. Time will tell
Add to My Watchlist
What is My Watchlist?
